A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer
Titel:
A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer
Auteur:
Heinemann, V. Di Gioia, D. Vehling-Kaiser, U. Harich, H.-D. Heinrich, B. Welt, A. Ziske, C. Deutsch, G. Pihusch, R. Kölbl, H. Hegewisch-Becker, S. Michl, M. Stemmler, H.J.